Esperion Therapeutics, Inc.·4

Dec 18, 4:13 PM ET

Warren Eric 4

4 · Esperion Therapeutics, Inc. · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-17
Warren Eric
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2024-12-17$2.43/sh2,234$5,426160,121 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files